These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 1892191

  • 1. Simultaneous measurements of prostacyclin and thromboxane metabolites during the menstrual cycle.
    Presser SC, Stanczyk FZ, Lobo RA.
    Am J Obstet Gynecol; 1991 Sep; 165(3):647-51. PubMed ID: 1892191
    [Abstract] [Full Text] [Related]

  • 2. Urinary excretion of thromboxane and prostacyclin metabolites during chronic low-dose aspirin: evidence for an extrarenal origin of urinary thromboxane B2 and 6-keto-prostaglandin F1 alpha in healthy subjects.
    Chiabrando C, Rivoltella L, Martelli L, Valzacchi S, Fanelli R.
    Biochim Biophys Acta; 1992 Feb 03; 1133(3):247-54. PubMed ID: 1737057
    [Abstract] [Full Text] [Related]

  • 3. The change of urinary 11-dehydro-thromboxane B2 and 2,3-dinor-6-keto-prostaglandin F1 alpha in arteriogenic impotence.
    Lin JS, Lui SM, Chen CM, Chang WC.
    J Urol; 1992 Aug 03; 148(2 Pt 1):311-3. PubMed ID: 1635125
    [Abstract] [Full Text] [Related]

  • 4. Urinary excretion of prostacyclin and thromboxane metabolites in threatened preterm labor: effect of indomethacin and nylidrin.
    Kurki T, Viinikka L, Ylikorkala O.
    Am J Obstet Gynecol; 1992 Jan 03; 166(1 Pt 1):150-4. PubMed ID: 1733190
    [Abstract] [Full Text] [Related]

  • 5. Urinary excretion of degradation products of prostacyclin and thromboxane is increased in patients with gestational choriocarcinoma.
    Aitokallio-Tallberg AM, Jung JK, Kim SJ, Viinikka LU, Ylikorkala RO.
    Cancer Res; 1991 Aug 15; 51(16):4146-8. PubMed ID: 1868436
    [Abstract] [Full Text] [Related]

  • 6. Quantitative profiling of 6-ketoprostaglandin F1 alpha, 2,3-dinor-6-ketoprostaglandin F1 alpha, thromboxane B2 and 2,3-dinor-thromboxane B2 in human and rat urine by immunoaffinity extraction with gas chromatography-mass spectrometry.
    Chiabrando C, Pinciroli V, Campoleoni A, Benigni A, Piccinelli A, Fanelli R.
    J Chromatogr; 1989 Oct 27; 495():1-11. PubMed ID: 2613794
    [Abstract] [Full Text] [Related]

  • 7. Desogestrel- and levonorgestrel-containing oral contraceptives have different effects on urinary excretion of prostacyclin metabolites and serum high density lipoproteins.
    Ylikorkala O, Kuusi T, Tikkanen MJ, Viinikka L.
    J Clin Endocrinol Metab; 1987 Dec 27; 65(6):1238-42. PubMed ID: 2960690
    [Abstract] [Full Text] [Related]

  • 8. Amniotic fluid 6-keto-prostaglandin F1 alpha and thromboxane B2 during labor.
    Mäkäräinen L, Ylikorkala O.
    Am J Obstet Gynecol; 1984 Nov 15; 150(6):765-8. PubMed ID: 6388335
    [Abstract] [Full Text] [Related]

  • 9. In vivo production of prostacyclin and thromboxane in patients with acute myocardial infarction.
    Henriksson P, Wennmalm A, Edhag O, Vesterqvist O, Green K.
    Br Heart J; 1986 Jun 15; 55(6):543-8. PubMed ID: 3521690
    [Abstract] [Full Text] [Related]

  • 10. Do prostacyclin and thromboxane contribute to the "protective effect" of pregnancies with chronic hypertension? A preliminary prospective longitudinal study.
    Moutquin JM, Lindsay C, Arial N, De Grandpré P, C-Gaudreault R, Forest JC, Massé J.
    Am J Obstet Gynecol; 1997 Dec 15; 177(6):1483-90. PubMed ID: 9423755
    [Abstract] [Full Text] [Related]

  • 11. Decreased systemic formation of prostaglandin E and prostacyclin, and unchanged thromboxane formation, in alcoholics during withdrawal as estimated from metabolites in urine.
    Förstermann U, Feuerstein TJ.
    Clin Sci (Lond); 1987 Sep 15; 73(3):277-83. PubMed ID: 3308287
    [Abstract] [Full Text] [Related]

  • 12. Altered excretion of prostaglandin and thromboxane metabolites in pregnancy-induced hypertension.
    Minuz P, Covi G, Paluani F, Degan M, Lechi C, Corsato M, Lechi A.
    Hypertension; 1988 Jun 15; 11(6 Pt 1):550-6. PubMed ID: 3290103
    [Abstract] [Full Text] [Related]

  • 13. Prostacyclin, thromboxane A and the effect of low-dose ASA in pregnancies at high risk for hypertensive disorders.
    Vainio M, Riutta A, Koivisto AM, Mäenpää J.
    Acta Obstet Gynecol Scand; 2004 Dec 15; 83(12):1119-23. PubMed ID: 15548142
    [Abstract] [Full Text] [Related]

  • 14. Measurements of urinary prostaglandins in young ovulatory women during the menstrual cycle and in postmenopausal women.
    Farker K, Schweer H, Vollandt R, Nassr N, Nagel U, Seyberth HW, Hoffmann A, Oettel M.
    Prostaglandins; 1997 Sep 15; 54(3):655-64. PubMed ID: 9373880
    [Abstract] [Full Text] [Related]

  • 15. Chronic effects of oral prostacyclin analogue on thromboxane A2 and prostacyclin metabolites in pulmonary hypertension.
    Ichida F, Uese K, Hamamichi Y, Hashimoto I, Tsubata S, Fukahara K, Murakami A, Miyawaki T.
    Acta Paediatr Jpn; 1998 Feb 15; 40(1):14-9. PubMed ID: 9583194
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Monitoring of the thromboxane A2/prostacyclin ratio in the urine of patients with retinal vascular occlusion through the low-dose-aspirin therapy using the gas chromatography/selected ion monitoring method.
    Mizugaki M, Hishinuma T, Matsumura E, Murai Y, Yamazaki T, Yamanobe S, Tamai M.
    Prostaglandins Other Lipid Mediat; 1999 Nov 15; 58(5-6):253-62. PubMed ID: 10593167
    [Abstract] [Full Text] [Related]

  • 18. Prostanoid excretion in incipient singleton and twin pregnancies.
    van der Weiden RM, Helmerhorst FM, Keirse MJ.
    Am J Obstet Gynecol; 1996 May 15; 174(5):1614-7. PubMed ID: 9065139
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prostacyclin and thromboxane in pregnant and nonpregnant women in response to exercise.
    Rauramo I, Ilmonen S, Viinikka L, Ylikorkala O.
    Obstet Gynecol; 1995 Jun 15; 85(6):1027-30. PubMed ID: 7770249
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.